NanoRepro AG

€1.56As of Sun 8 Nov 2026, 12:00 UTC
XETRA:NN6Healthcare
Country Germany
PE (Fwd) •••
TSR 10Y CAGR 6.49%
Div yield 9.59%
ROE (5.16%)
Diagnostics & Research
Beta (5Y) 0.55
PE TTM —
TSR TTM (7.40%)
Mkt cap €19.74M
ROIC (6.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€1.99
26.95%
(97.54%)
Hold 0|12|2|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.03
0.03
0.03
0.03
5.36%
13.86%
15.95%
20.40%
Revenue€M
2.286
2.383
2.450
2.382
9.50%
9.24%
7.75%
1.55%
Peers (US$22.16M)
Cap (US$)
PE
60.03M
—
22.02M
—
Capital
TTM
5Y
10Y
Leveragex
0.076
—
—
EBIT/Intx
0.792
0.659
0.687
Own earn%
(48.62)
(24.47)
(15.22)
Sh yield%
30.69
53.75
51.21
Owners
Insiders/Inst%
7.26
51.23
Short interest%
5.95
SBC / revenue%
4.53
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
29